Update: Eli Lilly’s Anti-COVID Product Approved by FDA
Bamlanivimab, a monoclonal antibody, can be used for anyone 65 or older. It can also be used for patients 12 and over who have an underlying health condition and have been diagnosed with mild-to-moderate COVID-19.
Reasons Given for Why the US Unable to Contain COVID-19
The MJH Life Sciences COVID-19 Coalition experts share their insights on the state of the pandemic.